Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies

Learn the latest evidence on the comprehensive management of dyslipidemia, including the importance of achieving LDL-C targets and addressing elevated Lp(a), to reduce ASCVD risk through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation